Please login to the form below
33
Revenue 2017Humalog
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humalog was produced by Lilly.
Eli Lilly to sell low blood sugar drug Baqsimi to Amphastar in deal worth over $1bn
The move comes just over a month after Lilly announced a 70% cut to the US prices of its most commonly prescribed insulins, Humalog and Humulin.
Sanofi to cut US insulin prices by up to 78% in January 2024
counter.”. Eli Lilly announced earlier this month that it would be lowering the US prices of its most commonly prescribed insulins, Humalog and Humulin, by 70%.
Eli Lilly announces 70% cut to US insulin prices while also capping out-of-pocket costs
The prices of Humalog and Humulin will be cut by 70% from the fourth quarter of this year.
Eli Lilly set to launch Tempo Personalized Diabetes Management Platform
The Tempo Pen is available for Lyumjev (insulin lispro-aabc) injection, 100 units/mL, Basaglar (insulin glargine) injection, 100 units/mL, and Humalog (insulin lispro injection) 100 units/mL.
Lilly joins new Medicare scheme to reduce insulin prices
Lilly has faced particularly strong criticism, after its widely-used Humalog insulin rose from $34 to $234 per vial between 2001 and 2015.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
